Shreya Life Sciences announced the launch of the world's first oral insulin spray as an alternative to the insulin injections. The spray is a recombinant DNA human insulin buccal spray and has been approved. The drug used to treat both Type 1 and Type 2 diabetes works by delivering insulin through buccal mucosa, directly to the vascular system without entering the lungs.
Treat: tractar
Lungs: pulmons
Entering: entrant
Cap comentari:
Publica un comentari a l'entrada